Stay updated with breaking news from Nasdaq Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Standard BioTools (NASDAQ:LAB – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Standard BioTools to similar businesses based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk. Analyst Ratings This is a breakdown […]
Standard BioTools (NASDAQ:LAB – Get Rating) is one of 43 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Standard BioTools to similar businesses based on the strength of its valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership. Analyst Recommendations This is a summary […]
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) major shareholder Caligan Partners Lp purchased 200,000 shares of Standard BioTools stock in a transaction that occurred on Thursday, June 2nd. The shares were purchased at an average price of $1.92 per share, for a total transaction of $384,000.00. Following the transaction, the insider now directly owns 10,173,188 […]
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (f/k/a Fluidigm Corporation) (Nasdaq:FLDM) today announced, as...